An NIDDK-supported study found that people who experienced acute kidney injury (AKI) during a hospitalization, including those admitted with AKI or who developed AKI in the hospital, were more likely to revisit the hospital or die shortly after discharge, compared to people hospitalized without AKI.

Researchers from NIH have outlined opportunities for achieving President Joe Biden and First Lady Dr. Jill Biden’s Cancer Moonshot national goal of reducing the cancer death rate by at least 50% over the next 25 years.

Expanded availability of opioid use disorder-related telehealth services and medications during the Covid-19 pandemic was associated with a lowered likelihood of fatal drug overdose among Medicare beneficiaries.

A clinical trial at NIH found that a medication, denosumab, significantly reduced abnormal bone turnover in adults with fibrous dysplasia, a rare disease marked by weak and misshapen bones.

An NIH clinical trial was stopped early because a daily statin medication was found to reduce the increased risk of cardiovascular disease among people living with HIV in the first large-scale clinical study to test a primary cardiovascular prevention strategy in this population.

NIH-funded researchers have developed a new imaging tool, called electromyometrial imaging (EMMI), to create real-time, three-dimensional images and maps of uterine contractions during labor.

Results of a new study, published in Biological Psychiatry, may help researchers develop more precise treatments to improve learning and memory in people with Down syndrome.

Scientists have identified an autoinflammatory disease caused by mutations in the LYN gene, an important regulator of immune responses in health and disease.

A clinical trial testing a freeze-dried, temperature-stable experimental tuberculosis (TB) vaccine in healthy adults found that it was safe and stimulated both antibodies and responses from the cellular arm of the immune system.

Scientists at NIH and Massachusetts General Hospital (MGH) have uncovered a potential new approach against liver cancer that could lead to the development of a new class of anti-cancer drugs.